Open AccessAspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction
Author(s) -
Jianjun Zhang,
Xin Liu
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000010123
Subject(s) - medicine , aspirin , dipyridamole , cilostazol , ticlopidine , clopidogrel , warfarin , stroke (engine) , adverse effect , randomized controlled trial , antiplatelet drug , anesthesia , surgery , atrial fibrillation , mechanical engineering , engineering
Supplemental Digital Content is available in the text